Nominations are now open for Union Awards 2020
Nominations are now being received for The Union Awards, to be presented at the 51st Union World Conference on Lung Health in Seville, Spain.
More details about each of the awards can be found on The Union website by clicking on the links below or on the nominations page.
Nominations are now open for the following prizes:
- The Union Young Investigator Prize: Acknowledges a researcher for work in lung health published in the past five years, when aged 35 years or younger.
- The Union Scientific Prize: Acknowledges researchers at any stage of their career for work in lung health published in the past five years.
- The Karel Styblo Public Health Prize: Acknowledges a health worker or a community organisation for contributions to tuberculosis (TB) control over a period of ten years or more.
- The Stephen Lawn TB-HIV Research Leadership Prize: Acknowledges young researchers conducting promising work focused on reducing the disease burden of TB and HIV/AIDS in Africa.
- The Princess Chichibu Global Memorial TB Award: Recognises outstanding contributions to global TB control. Awarded by the Japan Anti-Tuberculosis Association (JATA). For this award, the call for nominations is for award in 2021.
- The Union Medal – for members only: Awarded to members who have made an outstanding contribution to the control of TB or lung health by their scientific work and/or actions in the field.
- Honorary Member – for members only: Granted to a person who has become distinguished through active participation in The Union's activities and the fulfilment of its goals.
The awards will be presented at the 51st Union World Conference on Lung Health to be held from 21-24 October 2020 in Seville, Spain.
Nominations will close on 31 March 2020.
Any queries should be sent to awards@theunion.org for the first four scientific prizes in the list above, and to nominatingcommittee@theunion.org for The Union Medal, Honorary Member and Princess Chichibu Award.
Visit: https://www.theunion.org/what-we-do/awards/nomination-and-applications?utm_source=The+Union+Marketing&utm_campaign=04e1b26e47-EMAIL_CAMPAIGN_2020_02_13_04_39&utm_medium=email&utm_term=0_e2dbdf856e-04e1b26e47-248828829
Articles
13Th Edition Of The Edctp Forum To Take Place In Madrid, Spain, From 5 To 9 April 2027
We are delighted to announce that the 13th edition of the EDCTP Forum will be celebrated on 5-9 April 2027, at IFEMA Palacio Municipal in Madrid, Spain.
The event will be co-hosted by the Instituto de Salud Carlos III (ISCIII) under the Spanish Ministry of Science, Innovation and Universities and the Fundación CSAI (FCSAI) under the Ministry of Health, and is co-organised by Global Health EDCTP3 and the EDCTP Association.
Over the past two decades, the biennial European & Developing Countries Clinical Trials Partnership (EDCTP) Forum has evolved to become a cornerstone event for global health research, bringing together leading voices advancing the fight against infectious diseases in sub-Saharan Africa. It showcases the latest scientific breakthroughs, highlights impactful capacity-building efforts, and creates a space for vibrant cross-regional collaboration.
The EDCTP Forum 2027 expects to convene 1,500 participants and stakeholders, from researchers, universities and clinicians to governments, regional bodies, civil society, regulators, and public and private R&D partners, drawing participation primarily from Africa and Europe.
Dr Tuelo Mogashoa Becomes First Tagendi Phd Graduate
Botswana-born scientist Dr Tuelo Mogashoa, a PhD Fellow in the ‘Addressing Gender and Diversity Regional Gaps in Clinical Research Capacity’ (TAGENDI) programme, has successfully defended her PhD in Molecular Biology (Tuberculosis Genomics) at Stellenbosch University. Her virtual oral examination, held on 12 January 2025, marked the culmination of years of research and training.
Her doctoral thesis, titled “Rifampicin- resistant tuberculosis: an emerging threat to human health in Botswana,” addresses one of the most pressing challenges in TB control.
Dr Mogashoa is the first of seven PhD fellows from the inaugural TAGENDI cohort to complete her doctoral studies. The TAGENDI fellowship, implemented under the Trials of Excellence in Southern Africa (TESA) Network, is part of a dedicated PhD fellowship scheme launched by EDCTP2 in 2020 to support women in health research across sub-Saharan Africa. Coordinated by the EDCTP Networks of Excellence, the initiative received funding from the UK National Institute for Health and Care Research (Department of Health and Social Care).
As part of her PhD requirements, Dr Mogashoa was expected to produce four manuscripts, with at least two accepted in peer-reviewed journals. She has exceeded this requirement, publishing three peer-reviewed articles from her doctoral work, with a fourth manuscript currently under review.
Her journey highlights the transformative impact of long-term investment in research training, mentorship, and gender equity. As she moves into the next phase of her career, her work promises to make a meaningful contribution to improving TB diagnosis, treatment, and control.
More information:
- Dr Tuelo Mogashoa Successfully Defends PhD in TB Genomics
- Tuelo’s journey: building Botswana’s capacity for cutting-edge health research
Prof. Novel Chegou Elected As Fellow Of The African Academy Of Sciences
Prof. Novel Chegou, EDCTP Senior Fellow and Acting Head of the Division of Immunology at the Faculty of Medicine and Health Sciences, Stellenbosch University, has been elected as a Fellow of the African Academy of Sciences. This important achievement recognises his scientific leadership and impactful research on tuberculosis, particularly his work on biomarkers to improve diagnosis and patient care in resource-limited settings.
Read more